Yusuf maintained that it was only the President of the Federal Republic of Nigeria, who appointed him, that could remove him from office, which has tenure of five years in the first instance and another five, if renewed. "Aluta continua, Victoria Ascerta".
The Minister of Health Prof.
The Nigerian House of Representatives has ordered health minister Isaac Adewole to reverse the suspension of Executive Secretary of the National Health Insurance Scheme, Usman Yusuf, within a week.
Aminu Masari, said he was not going to obey the suspension order.
Members of the House were of the opinion that the minister, who was a President appointee, has no power to suspend another appointee of the President.
"With utmost respect sir, I am unable to comply with your directive".
Glaxosmithkline Plc (NYSE:GSK)'s Stock Is Buy After Less Market Selling
Heritage Trust Co bought a new stake in shares of GlaxoSmithKline PLC during the first quarter valued at about $123,000. Finally, Westwood Holdings Group Inc. boosted its stake in shares of GlaxoSmithKline PLC by 15.7% in the first quarter.
It is preposterous for Yusuf to flaunt the name of President Buhari.
According to Premium Times, the Senate had earlier launched an investigation into Yusuf's administration, accusing him of "corrupt expenditure of N292m" which he allegedly spent on health care training "without recourse to any appropriate approving authority". The mere fact that there are pending petitions against a public officer which is yet to be substantiated does not constitute a ground for suspension under the Public Service Rules.
But in its response on Friday, the health ministry in a statement signed and released by spokesperson, Boade Akinola, dissociated itself from Yusuf's letter and said that Yusuf as a public officer, is bound by the regulations governing the Public Service.
Yusuf also gave five reasons why he would not comply with the suspension order despite being directed he proceeds on a three months suspension.
He said the petitions referred to by the minister were also being investigated by the ICPC, which was yet to submit its findings.
The allegations came during the debate of a motion sponsored by Chairman, House Committee on Healthcare Services, Hon.